Newsroom Investors Who We Are Businesses NASDAQ: NVOS Investor Relations Reports & SEC Filings View all Company SEC Filings (EDGAR), click here Latest Reports Our reporting periods are: FY Q1: Sept - Nov FY Q2: Dec - Feb FY Q3: Mar - May FY Annual: Sept - Aug Presentations SEC Filings View all Company SEC Filings (EDGAR), click here Copy of Annual Reports Upon request, a hardcopy of the Company's annual report is available free of charge. Please contact us to request: Contact Stay connected with Investor news Follow us and stay up to date on what's happening at Novo Integrated Sciences CAUTION CONCERNING FORWARD LOOKING STATEMENTS Novo Integrated Sciences's Investor Relations website at www.novointegrated.com/investors and our corporate blog at novointegrated.com/newsroom as well as Novo Integrated Sciences's social media accounts, contain a significant amount of information about the company, including financial and other information for investors. Novo Integrated Sciences encourages investors to visit these websites from time to time, as information is updated and new information is posted. ROBERT MATTACCHIONE CEO, Novo Integrated Sciences Inc Follow Robert on LinkedIn CHRIS DAVID President, Novo Integrated Sciences Inc Follow Chris on LinkedIn Subscribe for Company Updates Email* Submit Follow Us Company Novo Integrated Sciences is a U.S. based parent company, publicly-traded on the Nasdaq Capital Markets (Nasdaq:NVOS), with both U.S. and Canadian based wholly owned subsidiaries. Currently, the Company’s revenue is generated solely by services and products provided by NHL’s team of multidisciplinary primary care clinicians and practitioners in Canada. Site Map Investors About Newsroom SEC Reports Careers Contact Address 11120 NE 2nd Street, Suite 100 Bellevue, Washington 98004 USA (888) 512-1195 info@novointegrated.com Disclaimer Privacy Copyright © 2000 - 2021 Novo Integrated Sciences Inc. All rights reserved